BioSpace News Archive

ImmunoGen, Inc. announced that the following presentations by Company management at upcoming investor conferences will be webcast: Cowen 43rd Annual Health Care Conference March 8 at 9:10am ET Barclays Global Healthcare Conference March 15 at 10:15am ET A webcast of each presentation will be accessible through the “Investors and Media” section of the Company’s website, www.immunogen.com.

Thermo Fisher Scientific Inc., the world leader in serving science, announced that its Board of Directors has authorized a quarterly cash dividend of $0.35 per common share payable on April 14, 2023, to stockholders of record as of March 15, 2023.

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) (“Genomma Lab” or “the Company”), today announced its results for the fourth quarter and full year ended December 31, 2022.

Apellis Pharmaceuticals, Inc. announced the pricing of its underwritten public offering of 3,174,603 shares of its common stock at a public offering price of $63.00 per share.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2022 and provided its financial guidance for the year ending December 31, 2023.

Agilent Technologies Inc. announced a quarterly dividend of 22.5 cents per share of common stock will be paid on April 26, 2023, to all shareholders of record as of the close of business on April 4, 2023.

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its fourth quarter and full year 2022 financial results on Thursday, March 9, 2023, prior to market open.

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the Company will present at the upcoming Canaccord Genuity 2023 Musculoskeletal Conference in Las Vegas, NV.

Nexus Pharmaceuticals, Inc. announced the launch of its new product line – Sterile Vials from Nexus Pharmaceuticals.

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its fourth quarter of 2022 ended December 31, 2022, after the market closes on Tuesday, February 28, 2023, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.